Literature DB >> 21139668

Evaluation of two commercial lateral flow devices (LFDs) used for flockside testing of H5N1 highly-pathogenic avian influenza infections in backyard gallinaceous poultry in Egypt.

Mohammed Soliman1, Abdullah Selim, Vivien J Coward, Mohammed K Hassan, Mona M Aly, Jill Banks, Marek J Slomka.   

Abstract

Quickvue and Anigen lateral flow devices (LFDs) were evaluated for detection of H5N1 highly pathogenic avian influenza (HPAI) infections in Egyptian poultry. Sixty five chickens and two turkeys were sampled in eight flocks where H5N1 HPAI infection was suspected. Swabs (tracheal and cloacal) and feathers were collected from each bird for flockside testing by the two LFDs. The same clinical specimens were transported for laboratory testing by M gene RRT PCR where a positive result by this "gold standard" test for one or both swabs from a given bird indicated infection at the bird level, showing 57 birds (including 15 carcassess) to be truly AI infected. Among these 57, similar bird-level LFD testing of swabs showed 43 and 44 to be AI infected by Quickvue and Anigen LFDs, respectively. Nine birds were AI negative by M gene RRT PCR and both LFDs, and one was M gene RRT PCR negative but positive by both LFDs, suggesting one false positive LFD result. Sensitivities of the LFDs relative to M gene RRT PCR were 77.2% for Anigen and 75.4% for Quickvue tests, with 90.0% specificity for both. By including feathers with swabs for LFD testing, the number of LFD positives among 57 infected birds increased by four to 48 by Anigen and 47 by Quickvue, increasing the sensitivity of the LFDs to 84.2% and 82.5% for Anigen and Quickvue, respectively. Although LFD sensitivity cannot compare to the high sensitivity displayed by validated AI RRT PCRs, they may be utilised for flockside testing of birds infected with HPAI at the peak of viral shedding, when birds are displaying advanced clinical signs or sampled as fresh carcasses. Swabs are classic field specimens collected from outbreaks, but inclusion of feathers from birds infected with H5N1 HPAI increased LFD sensitivity. However, the LFD false positive observation emphasises the importance of returning samples for confirmatory laboratory testing.

Entities:  

Keywords:  H5N1 HPAI; Lateral flow device (LFD); flockside

Year:  2010        PMID: 21139668      PMCID: PMC2981883          DOI: 10.4172/1747-0862.1000043

Source DB:  PubMed          Journal:  J Mol Genet Med        ISSN: 1747-0862


INTRODUCTION

Interest in rapid flockside diagnosis of avian influenza (AI) infections in poultry has increased in recent years, particularly following the emergence and extensive spread of H5N1 highly pathogenic (HP) AI (Alexander, 2007; Brown, 2010). H5N1 HPAI is a continuing epizootic, which has become endemic in some countries while public health remains a concern (Capua and Alexander, 2007). Laboratory methods for AI diagnosis are outlined in the European Union (EU) and the World Organisation for Animal Health (OIE) Diagnostic Manuals, in which virus isolation (VI) in embryonated fowl eggs continues to serve as the gold standard (EU, 2006; OIE, 2009). Real-time reverse transcription-PCR (RRT-PCR) has emerged as a rapid, highly-sensitive and specific tool for AI laboratory diagnosis (Hoffmann et al, 2009), and optimised protocols are at least as sensitive as VI (Slomka et al, 2010). However, the potential rapidity with which HPAI outbreaks may spread remains a concern. Several commercial lateral flow device (LFD) tests are available for rapid flockside testing of AI. LFD evaluations have been described using field specimens collected during H5N1 HPAI outbreaks (Chua et al, 2007; Loth et al, 2008) and from experimentally-infected birds (Marché and van den Berg, 2010). In Egypt, H5N1 HPAI first occurred in 2006 (Aly et al, 2008) and is now considered endemic (Cattoli et al, 2009). This study describes the evaluation of two commercial AI LFDs in Egypt during 2009, and focused on suspected H5N1 HPAI outbreaks in backyard poultry, from which tracheal and cloacal swabs were collected and tested by LFDs in the field. Tracheal and cloacal swabs were also collected from the same birds for testing by M gene RRT-PCR in order to provide a highly-sensitive and specific determination of whether they were truly AI infected. Feathers collected from all swabbed birds were also tested by LFDs and M gene RRT-PCR.

MATERIALS AND METHODS

Lateral flow devices (LFDs)

The Quickvue Influenza Test (Quidel) and the AIV Ag Test kit (Anigen) were used following the manufacturers' protocols. Feather samples were similarly expressed into the kits' LFD extraction buffers for testing.

Samples from poultry flocks

Swabs (tracheal and cloacal) and feathers were collected between February and April 2009 in Egypt from 65 chickens and two turkeys from eight backyard poultry flocks in which clinical signs were observed with suspicion of H5N1 HPAI infection. Chickens included 15 carcasses of recently dead birds from four flocks. No apparently healthy flocks were sampled in this study.

Sampling protocol in the field

Six swabs were taken from each bird, consisting of three from the trachea and three from the cloaca. The order of swabbing was carefully noted. Young feathers (maximum 4-5cm long) of immature character, which possessed calami that had not calcified, were also collected from each bird. Swabs were tested by the two AI LFDs. For the first bird the first swabs (tracheal and cloacal) were tested by the Quickvue LFD, while the second swabs (tracheal and cloacal) were tested by the Anigen LFD. For the next bird the order of swab testing was reversed for the two AI LFDs. This alternating approach was continued throughout for all sampled birds. Flockside LFD testing was conducted at the location of the suspected outbreaks. The third swabs (tracheal and cloacal) taken from each bird were transported on ice on the same day to the laboratory at NLQP, Dokki, Egypt, where 1ml of brain heart infusion broth containing antibiotics (BHIB) was added. Feathers from each bird were divided into three portions; two lots of 2-3 feather calami were tested flockside by each LFD. Each third feather portion was transported to the laboratory where they were expressed in 1ml BHIB. All BHIB fluids were stored frozen at -80C until required for RNA extraction.

RNA extraction, AI RRT-PCRs, virus isolation and typing

RNA was extracted from 140μl of BHIB as previously described (Slomka et al, 2007). M gene RRT-PCR (Spackman et al, 2002) was used as recommended in the EU AI Diagnostic Manual (EU, 2006) to provide “gold standard” AI qualitative results in comparison to corresponding LFD results as described by Loth et al (2008). H5N1 infection was confirmed by a combination of VI, classical subtyping and H5 RRT-PCR (EU, 2006; OIE, 2009; Slomka et al, 2007).

RESULTS

AI infected birds by M gene RRT-PCR

Sixty-seven birds from eight backyard flocks were assessed as to whether they were positive for AI infection on the basis of testing tracheal and cloacal swabs, this being the normal sampling approach during AI outbreak investigations (OIE, 2009). An individual bird was considered infected if either or both swabs were positive by M gene RRT-PCR. By this test 57 birds (56 chickens and one turkey) were diagnosed to be truly AI infected, including 15 chicken carcasses (Figure 1). Testing of feathers by M gene RRT PCR did not reveal any additional AI-infected birds. Hence we did not find any birds that were M gene RRT PCR negative on swabs but positive on feathers. H5N1 infection was confirmed in seven flocks, with one being AI negative.
Figure 1.

Diagnosis of AI infection in 65 chickens and two turkeys at the individual bird level by M gene RRT PCR and LFDs. Five categories of test result at the bird level are illustrated. For a given bird to have been considered positive by a given test, at least one of the clinical specimens had given a positive result. A. Presents bird-level results on the basis of testing swabs only, while (B) presents bird-level results from the testing of swabs and feathers. The segment indicating 15 carcasses is shown detached from the four other segments that contain 52 live birds from diseased flocks.

AI LFD comparison to M gene RRT PCR

This was made between results obtained for individual birds by each of the two LFDs and the M gene RRT-PCR, initially on the basis of testing two swabs per bird. Of the 42 live infected birds, 28 were also positive by the Quickvue LFD. These 28 birds plus one additional chicken were found positive by the Anigen LFD (Figure 1A). The 15 carcasses were AI positive by both LFDs and the M gene RRT-PCR (Figure 1A). Nine birds were negative by LFDs (both tests) and M gene RRT-PCR. One bird was considered to be a false-positive by both AI LFDs as it was M gene RRT-PCR negative (Figure 1A). Comparison of these methods for swabs revealed that for individual birds (live and carcasses) the Anigen and Quickvue LFD sensitivities were 77.2% and 75.4%, respectively (Table 1A).
Table 1.

Diagnostic sensitivity and specificity calculations for LFD tests relative to M gene RRT-PCR determined at the level of individual birds.

Diagnosis of AI infection in 65 chickens and two turkeys at the individual bird level by M gene RRT PCR and LFDs. Five categories of test result at the bird level are illustrated. For a given bird to have been considered positive by a given test, at least one of the clinical specimens had given a positive result. A. Presents bird-level results on the basis of testing swabs only, while (B) presents bird-level results from the testing of swabs and feathers. The segment indicating 15 carcasses is shown detached from the four other segments that contain 52 live birds from diseased flocks. Diagnostic sensitivity and specificity calculations for LFD tests relative to M gene RRT-PCR determined at the level of individual birds. When feather samples were included as a third clinical specimen, the numbers of true positive live birds identified by LFDs increased to 33 and 32 for the Anigen and Quickvue tests, respectively (compare Figure 1A with 1B). Therefore, testing of three specimens as opposed to two swabs increased the number of LFD positive birds by four for each LFD. When tested by swabs only, these four chickens were all M gene RRT-PCR positive by one or both swabs, but LFD negative by both swabs (see Figure 1A and 1B). Inclusion of feathers with swabs from all birds (live and carcasses) increased LFD sensitivity to 84.2% and 82.5% for Anigen and Quickvue LFDs, respectively (Table 1B). The specificity for each LFD was 90% for testing two swabs with or without feathers (Table 1A and 1B). However, the relatively small number (10) of true AI negative birds in the study population, identified as such by M gene RRT-PCR, was reflected in the broad 95% confidence intervals (CIs; Table 1A and 1B).

Comparison of the type of clinical specimens

Diagnostic sensitivity and specificity of the LFDs was determined separately for each type of specimen regardless of the test results for the other two clinical specimens from the same bird (Table 2). For tracheal swabs, both LFDs displayed a sensitivity of 69.8% and specificity of 92.9% (Table 2A). For cloacal swabs, the Anigen LFD had a sensitivity of 76.5% and a specificity of 87.5%, while the Quickvue LFD had a sensitivity of 75% and specificity of 100% (Table 2B). For feather samples, a lower sensitivity of 65.1% was observed with a specificity of 91.7% for both LFDs (Table 2C).
Table 2.

Diagnostic sensitivity and specificity calculations for LFD tests relative to M gene RRT-PCR, determined separately for each of the three clinical specimens.

Diagnostic sensitivity and specificity calculations for LFD tests relative to M gene RRT-PCR, determined separately for each of the three clinical specimens.

DISCUSSION

Several commercial LFDs for AI detection have emerged in the veterinary diagnostics market in recent years that could be employed for rapid flockside testing of poultry. This methodology has the potential of saving time and accelerates important decision-making processes necessary for effective AI outbreak management. However, there has been a paucity of published validation data concerning LFD test performance. Emergence of the continuing H5N1 HPAI epidemic, initially in Asia followed by spread to Europe and Africa, has coincided with an interest in what role LFDs may play in local outbreak management. It must be emphasised that the OIE Diagnostic Manual for AI currently does not recommend LFDs for AI diagnosis and is unlikely to do so until rigorous and robust validation data accumulates, which may indicate in which particular AI infection situations LFDs may have a role (OIE, 2009). The analytical sensitivity limit of the Anigen and Quickvue LFDs was shown to be approximately 10,000 50% egg-infectious doses (EID50)/ml (data not shown), which is at least three orders of magnitude less than the detection limit of optimised highly-sensitive AI RRT-PCRs (Spackman et al, 2002; Slomka et al, 2007; Slomka et al, 2009). Despite the sensitivity limitations of LFDs, examination of AI RRT-PCR data obtained during outbreak investigations suggested that LFDs may be sufficiently sensitive to give positive AI results with high-titre swabs obtained from diseased or recently-dead H5N1 HPAI infected galliformes (Slomka et al, 2010). The endemic H5N1 HPAI poultry situation in Egypt provided a setting where LFDs could be evaluated prospectively through flockside testing. Loth et al (2008) tested only oro-pharyngeal swabs from 155 chickens sampled in diseased back-yard flocks in Indonesia by the Anigen and FluDetect (Synbiotics) LFDs, and reported a sensitivity of 69% and 71%, respectively, relative to M gene RRT-PCR. This is a very similar finding to the 69.8% sensitivity for the Anigen and Quickvue LFD testing of tracheal swabs from chickens and turkeys in Egypt (Table 2A) where flocks were similarly sampled on suspicion of HPAI. However, the current study showed that if sampling included more clinical specimens per bird, test sensitivity increased from 69.8% (both LFDs) for tracheal swabs alone (Table 2A), to 77.2% (Anigen) and 75.4% (Quickvue) for tracheal swabs plus cloacal swabs, to 84.2% (Anigen) and 82.5% (Quickvue) for swabs and feathers (Tables 1). Testing of chicken and turkey swabs plus feathers from H5N1 HPAI infected flocks demonstrated that the two LFDs can correctly identify a significant number of true AI infections, provided that swabs are collected from birds that are either recently dead due to HPAI or displaying advanced clinical signs of HPAI disease, when it is known that respiratory and enteric shedding of HPAI is at maximum titre (Slomka et al, 2010). It may be more cost-effective to collect only one type of swab, provided that sufficient numbers of birds are sampled per flock (Loth et al, 2008). It is unlikely that LFDs would detect H5N1 HPAI shedding in infected gallinaceous poultry sampled at the pre-clinical stage, as much lower titres of AI are observed at the early stage of HPAI infection (Slomka et al, 2010). This has been demonstrated in a recent study which included LFD testing of swabs from H5N1 HPAI experimentally-infected chickens at the early pre-clinical stage (Marché and van den Berg, 2010). A specificity of 90% was observed for LFD testing of individual Egyptian birds by testing two swabs with or without feathers (Table 1). The broad CI range reflected the relatively small numbers of true uninfected (i.e., M gene RRT-PCR-negative) chickens in the study population (10 birds), which excluded rigorous assessment of LFD specificity. However, the 90% specificity underlined the importance of confirming that flocks positive by LFD flockside testing are positive by laboratory testing, for which the proven sensitivity and specificity of VI and AI RRT-PCR provides a more accurate result. Some LFD false positives were also observed in the Indonesian LFD evaluation, where the Anigen LFD had 98% specificity (Loth et al, 2008). Although not highly sensitive, LFDs can successfully detect HPAI shedding in diseased gallinaceous poultry. Advantages of flockside testing Testing feathers in addition to swabs from HPAI infected chickens and turkeys increases the sensitivity of the LFDs. Clinical specimens still need to be sent to the laboratory for confirmatory testing by more sensitive and specific methods.
  13 in total

1.  Evaluation of rapid antigen detection kits for the diagnosis of highly pathogenic avian influenza H5N1 infection.

Authors:  Sylvie Marché; Thierry van den Berg
Journal:  Avian Dis       Date:  2010-03       Impact factor: 1.577

2.  Summary of avian influenza activity in Europe, Asia, and Africa, 2006-2009.

Authors:  Ian H Brown
Journal:  Avian Dis       Date:  2010-03       Impact factor: 1.577

3.  Role of real-time RT-PCR platform technology in the diagnosis and management of notifiable avian influenza outbreaks: experiences in Great Britain.

Authors:  M J Slomka; R M Irvine; T Pavlidis; J Banks; I H Brown
Journal:  Avian Dis       Date:  2010-03       Impact factor: 1.577

Review 4.  An overview of the epidemiology of avian influenza.

Authors:  Dennis J Alexander
Journal:  Vaccine       Date:  2006-11-09       Impact factor: 3.641

5.  Validated H5 Eurasian real-time reverse transcriptase-polymerase chain reaction and its application in H5N1 outbreaks in 2005-2006.

Authors:  M J Slomka; T Pavlidis; J Banks; W Shell; A McNally; S Essen; I H Brown
Journal:  Avian Dis       Date:  2007-03       Impact factor: 1.577

Review 6.  Animal and human health implications of avian influenza infections.

Authors:  Ilaria Capua; Dennis J Alexander
Journal:  Biosci Rep       Date:  2007-12       Impact factor: 3.840

7.  Performance evaluation of five detection tests for avian influenza antigen with various avian samples.

Authors:  Tze-Hoong Chua; Trevor M Ellis; Chun W Wong; Yi Guan; Sheng Xiang Ge; Geng Peng; Chinta Lamichhane; Con Maliadis; Sze-wee Tan; Paul Selleck; John Parkinson
Journal:  Avian Dis       Date:  2007-03       Impact factor: 1.577

8.  Evaluation of two avian influenza type A rapid antigen tests under Indonesian field conditions.

Authors:  Leo Loth; Walujo Budi Prijono; Hendra Wibawa; Tri Bhakti Usman
Journal:  J Vet Diagn Invest       Date:  2008-09       Impact factor: 1.279

9.  Highly pathogenic avian influenza virus subtype H5N1 in Africa: a comprehensive phylogenetic analysis and molecular characterization of isolates.

Authors:  Giovanni Cattoli; Isabella Monne; Alice Fusaro; Tony M Joannis; Lami H Lombin; Mona M Aly; Abdel S Arafa; Katharine M Sturm-Ramirez; Emmanuel Couacy-Hymann; Joseph A Awuni; Komla B Batawui; Kodzo A Awoume; Gilbert L Aplogan; Adama Sow; Andrè C Ngangnou; Iman M El Nasri Hamza; Djibo Gamatié; Gwenaelle Dauphin; Joseph M Domenech; Ilaria Capua
Journal:  PLoS One       Date:  2009-03-17       Impact factor: 3.240

10.  Validated RealTime reverse transcriptase PCR methods for the diagnosis and pathotyping of Eurasian H7 avian influenza viruses.

Authors:  Marek J Slomka; Theo Pavlidis; Vivien J Coward; John Voermans; Guus Koch; Amanda Hanna; Jill Banks; Ian H Brown
Journal:  Influenza Other Respir Viruses       Date:  2009-07       Impact factor: 4.380

View more
  1 in total

1.  Evaluation of lateral flow devices for identification of infected poultry by testing swab and feather specimens during H5N1 highly pathogenic avian influenza outbreaks in Vietnam.

Authors:  Marek J Slomka; Thanh L To; Hien H Tong; Vivien J Coward; Ian C Mawhinney; Jill Banks; Ian H Brown
Journal:  Influenza Other Respir Viruses       Date:  2011-12-12       Impact factor: 4.380

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.